Alex Fudukidis | Director of Investor Relations |
Adi Hoess | Chief Executive Officer |
Andreas Harstrick | Chief Medical Officer |
Angus Smith | Chief Financial Officer |
Wolfgang Fischer | Chief Operating Officer |
Arndt Schottelius | Chief Scientific Officer |
Maurice Raycroft | Jefferies |
Daina Graybosch | Leverink Partners |
Li Watsek | Cantor Fitzgerald |
Yale Jen | Laidlaw & Co |
Yanan Zhu | Wells Fargo Securities |
Srikripa Devarakonda | Truist Securities |
Andy Chen | Berenberg |
Good day, everyone, and welcome to Affimed’s Second Quarter 2023 Earnings and Corporate Update Call.
As a reminder, today's conference call is being recorded.
I would now like to introduce your host for today's call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Thank you, Chris, and thank you all for joining us today for our second quarter 2023 update call.